AIMS: To investigate alpha catenin expression in surgically resected human colorectal cancers to evaluate its prognostic value during long term follow up. METHODS: Immunohistochemistry was used to compare the expression of alpha catenin with conventional prognostic factors in 187 colorectal cancer patients treated in Kuopio University Hospital and followed up for a mean of 14 years. The hypothesis that the intensity of expression of alpha catenin and its distribution in cancer cells is correlated with survival was tested with the long-rank test, hazard ratios, and their confidence intervals. RESULTS: Uniform membranous alpha catenin staining localised to the intercellular borders was observed in 46% of the tumours; 55% of all tumours had either heterogeneous or negative alpha catenin expression, and staining intensity was either negative or weak in 42% of the tumours. The cancer related and recurrence-free survival rates were lower among patients with a weak alpha catenin intensity in tumour epithelium (p < 0.001), a low fraction of positive tumour cells (p < 0.001), and an additional cytoplasmic accumulation of alpha catenin (p < 0.001). In multivariate analysis, the intensity of alpha catenin expression in tumour epithelium predicted cancer related survival independently; alpha catenin localisation in tumour epithelium was an independent prognostic factor of recurrence-free survival in the group as a whole and in the T1-3N0M0 tumour subgroup. CONCLUSIONS: A low proportion of positive carcinoma cells, additional cytoplasmic accumulation of alpha catenin, and reduced expression intensity in tumour epithelium predict a poor survival rate. The results suggest that alpha catenin has prognostic significance in colorectal cancer.
AIMS: To investigate alpha catenin expression in surgically resected humancolorectal cancers to evaluate its prognostic value during long term follow up. METHODS: Immunohistochemistry was used to compare the expression of alpha catenin with conventional prognostic factors in 187 colorectal cancerpatients treated in Kuopio University Hospital and followed up for a mean of 14 years. The hypothesis that the intensity of expression of alpha catenin and its distribution in cancer cells is correlated with survival was tested with the long-rank test, hazard ratios, and their confidence intervals. RESULTS: Uniform membranous alpha catenin staining localised to the intercellular borders was observed in 46% of the tumours; 55% of all tumours had either heterogeneous or negative alpha catenin expression, and staining intensity was either negative or weak in 42% of the tumours. The cancer related and recurrence-free survival rates were lower among patients with a weak alpha catenin intensity in tumour epithelium (p < 0.001), a low fraction of positive tumour cells (p < 0.001), and an additional cytoplasmic accumulation of alpha catenin (p < 0.001). In multivariate analysis, the intensity of alpha catenin expression in tumour epithelium predicted cancer related survival independently; alpha catenin localisation in tumour epithelium was an independent prognostic factor of recurrence-free survival in the group as a whole and in the T1-3N0M0 tumour subgroup. CONCLUSIONS: A low proportion of positive carcinoma cells, additional cytoplasmic accumulation of alpha catenin, and reduced expression intensity in tumour epithelium predict a poor survival rate. The results suggest that alpha catenin has prognostic significance in colorectal cancer.
Authors: T Shimazui; P P Bringuier; H van Berkel; E Ruijter; H Akaza; F M Debruyne; E Oosterwijk; J A Schalken Journal: Int J Cancer Date: 1997-10-21 Impact factor: 7.396
Authors: Y Nakanishi; A Ochiai; S Akimoto; H Kato; H Watanabe; Y Tachimori; S Yamamoto; S Hirohashi Journal: Oncology Date: 1997 Mar-Apr Impact factor: 2.935
Authors: S Matsui; H Shiozaki; M Inoue; S Tamura; Y Doki; T Kadowaki; T Iwazawa; K Shimaya; A Nagafuchi; S Tsukita Journal: Virchows Arch Date: 1994 Impact factor: 4.064
Authors: T Shimazui; J A Schalken; L A Giroldi; C F Jansen; H Akaza; K Koiso; F M Debruyne; P P Bringuier Journal: Cancer Res Date: 1996-09-15 Impact factor: 12.701
Authors: M J Pukkila; J A Virtaniemi; E J Kumpulainen; R T Pirinen; R T Johansson; H J Valtonen; M T Juhola; V M Kosma Journal: J Clin Pathol Date: 2001-01 Impact factor: 3.411
Authors: Nancy Van Damme; Pieter Demetter; Wouter De Bock; Marianne Rottiers; Marleen Praet; Bernard de Hemptinne; Marc Peeters Journal: World J Gastroenterol Date: 2005-09-14 Impact factor: 5.742
Authors: T Chiyomaru; H Enokida; S Tatarano; K Kawahara; Y Uchida; K Nishiyama; L Fujimura; N Kikkawa; N Seki; M Nakagawa Journal: Br J Cancer Date: 2010-02-16 Impact factor: 7.640
Authors: K A Voutilainen; M A Anttila; S M Sillanpää; K M Ropponen; S V Saarikoski; M T Juhola; V-M Kosma Journal: J Clin Pathol Date: 2006-02-03 Impact factor: 3.411